Pulmonary dysfunction in pediatric hematopoietic stem cell transplant patients: Non-infectious and long-term complications

Pediatric Blood and Cancer

Volumn 49, Issue 3, 2007, Pages 225-233

  Gower, W Adam ^a   Collaco, J Michael ^a   Mogayzel Jr , Peter J ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Hematopoietic stem cell transplantation (HSCT); Non infectious complications; Pediatric bone marrow transplantation (BMT); Pulmonary complication

Indexed keywords

ALKYLATING AGENT; ANTIMETABOLITE; ANTINEOPLASTIC AGENT; AZATHIOPRINE; AZITHROMYCIN; BLEOMYCIN; BUSULFAN; CARMUSTINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; DIURETIC AGENT; GRANULOCYTE COLONY STIMULATING FACTOR; IMATINIB; INTERLEUKIN 2; METHOTREXATE; MITOMYCIN C; MITOXANTRONE; NARCOTIC ANALGESIC AGENT; NITROSOUREA; OXYGEN; PROCARBAZINE; RAPAMYCIN; RETINOIC ACID; STEROID; THALIDOMIDE; UNINDEXED DRUG; VINBLASTINE; VINDESINE;

ADULT RESPIRATORY DISTRESS SYNDROME; BRONCHIOLITIS OBLITERANS; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; BRONCHOSPASM; CAPILLARY LEAK SYNDROME; COUGHING; DIAGNOSTIC IMAGING; DRUG MEGADOSE; DRUG WITHDRAWAL; DYSPNEA; ENGRAFTMENT SYNDROME; FEVER; FLUID THERAPY; GRAFT VERSUS HOST REACTION; HEART DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IDIOPATHIC DISEASE; INTERSTITIAL PNEUMONIA; KIDNEY DYSFUNCTION; LOEFFLER PNEUMONIA; LUNG ALVEOLUS PROTEINOSIS; LUNG DISEASE; LUNG EDEMA; LUNG EMBOLISM; LUNG FIBROSIS; LUNG FUNCTION; LUNG HEMORRHAGE; LUNG INJURY; LUNG NODULE; LUNG VEIN OBSTRUCTION; LYMPHOPROLIFERATIVE DISEASE; MUCOSA INFLAMMATION; PLEURA EFFUSION; PNEUMOMEDIASTINUM; PNEUMONIA; PNEUMOTHORAX; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RADIATION PNEUMONIA; REVIEW; SUBCUTANEOUS EMPHYSEMA; THORAX DRAINAGE; THORAX RADIOGRAPHY; TRANSFUSION RELATED ACUTE LUNG INJURY; UPPER RESPIRATORY TRACT OBSTRUCTION;

CHILD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LUNG DISEASES;

EID: 34547824654     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21060     Document Type: Review

References (114)

1. Griese M, Rampf U, Hofmann D, et al. Pulmonary complications after bone marrow transplantation in children: Twenty-four years of experience in a single pediatric center. Pediatr Pulmonol 2000;30:393-401.
2. Collaco JM, Gower WA, Mogayzel PJ, Jr. Pulmonary dysfunction in pediatric hematopoietic stem cell transplant patients: Overview, diagnostic considerations and infectious complications. Pediatr Blood Cancer 2006; (in press).
3. Meyer S, Reinhard H, Gottschling S, et al. Pulmonary dysfunction in pediatric oncology patients. Pediatr Hematol Oncol 2004;21:175-195.
4. Khurshid I, Anderson LC. Non-infectious pulmonary complications after bone marrow transplantation. Postgrad Med J 2002;78:257-262.
5. Drew B, Peters C, Rimell F. Upper airway complications in children after bone marrow transplantation. Laryngoscope 2000;110:1446-1451.
6. Chaimberg KH, Cravero JP. Mucositis and airway obstruction in a pediatric patient. Anesth Analg 2004;99:59-61.
7. Barker CC, Anderson RA, Sauve RS, et al. GI complications in pediatric patients post-BMT. Bone Marrow Transplant 2005;36:51-58.
8. Fauroux B, Meyer-Milsztain A, Boccon-Gibod L, et al. Cytotoxic drug-induced pulmonary disease in infants and children. Pediatr Pulmonol 1994;18:347-355.
9. Ozkaynak MF, Weinberg K, Kohn D, et al. Hepatic venoocclusive disease post-bone marrow transplantation in children conditioned with busulfan and cyclophosphamide: Incidence, risk factors, and clinical outcome. Bone Marrow Transplant 1991;7:467-474.
10. Suzuki T, Saijo Y, Ebina M, et al. Bilateral pneumothoraces with multiple bullae in a patient with asymptomatic bronchiolitis obliterans 10 years after bone marrow transplantation. Bone Marrow Transplant 1999;23:829-831.
11. Kudoh T, Suzuki N, Oda T, et al. Pneumomediastinum, subcutaneous emphysema, and pulmonary fibrosis in a patient with idiopathic pneumonia syndrome after bone marrow transplantation. Pediatr Hematol Oncol 2000;17:113-117.
12. Hayes-Jordan A, Benaim E, Richardson S, et al. Open lung biopsy in pediatric bone marrow transplant patients. J Pediatr Surg 2002;37:446-452.
13. Madero L, Ruano D, Villa M, et al. Non-tunneled catheters in children undergoing bone marrow transplantation. Bone Marrow Transplant 1996;17:87-89.
14. Abid SH, Malhotra V, Perry MC. Radiation-induced and chemotherapy-induced pulmonary injury. Curr Opin Oncol 2001;13:242-248.
15. Movsas B, Raffin TA, Epstein AH, et al. Pulmonary radiation injury. Chest 1997;111:1061-1076.
16. Sanchez R, Toy P. Transfusion related acute lung injury: A pediatric perspective. Pediatr Blood Cancer 2005;45:248-255.
17. Looney MR, Gropper MA, Matthay MA. Transfusion-related acute lung injury: A review. Chest 2004;126:249-258.
18. Leach M, Vora AJ, Jones DA, Lucas G. Transfusion-related acute lung injury (TRALI) following autologous stem cell transplant for relapsed acute myeloid leukaemia: A case report and review of the literature. Transfus Med 1998;8:333-337.
19. Goldsby R, Pulsipher M, Adams R, et al. Unexpected pleural effusions in 3 pediatric patients treated with STI-571. J Pediatr Hematol Oncol 2002;24:694-695.
20. Takatsuka H, Takemoto Y, Mori A, et al. Common features in the onset of ARDS after administration of granulocyte colony-stimulating factor. Chest 2002;121:1716-1720.
21. Chhajed PN, Dickenmann M, Bubendorf L, et al. Patterns of pulmonary complications associated with sirolimus. Respiration 2006;73:367-374.
22. Benkerrou M, Jais JP, Leblond V, et al. Anti-B-cell monoclonal antibody treatment of severe posttransplant B-lymphoproliferative disorder: Prognostic factors and long-term outcome. Blood 1998;92:3137-3147.
23. Kang SK, Kirkpatrick JP, Halperin EC. Low-dose radiation for posttransplant lymphoproliferative disorder. Am J Clin Oncol 2003;26:210-214.
24. Collins MH, Montone KT, Leahey AM, et al. Autopsy pathology of pediatric posttransplant lymphoproliferative disorder. Pediatrics 2001;107:E89.
25. Collins MH, Montone KT, Leahey AM, et al. Post-transplant lymphoproliferative disease in children. Pediatr Transplant 2001;5:250-257.
26. Claviez A, Tiemann M, Wagner HJ, et al. Epstein-Barr virus-associated post-transplant lymphoproliferative disease after bone marrow transplantation mimicking graft-versus-host disease. Pediatr Transplant 2000;4:151-155.
27. Lones MA, Kirov I, Said JW, et al. Post-transplant lymphoproliferative disorder after autologous peripheral stem cell transplantation in a pediatric patient. Bone Marrow Transplant 2000;26:1021-1024.
28. Monforte-Munoz H, Kapoor N, Saavedra JA. Epstein-Barr virus-associated leiomyomatosis and posttransplant lymphoproliferative disorder in a child with severe combined immunodeficiency: Case report and review of the literature. Pediatr Dev Pathol 2003;6:449-457.
29. Clark JG, Hansen JA, Hertz MI, et al. NHLBI workshop summary. Idiopathic pneumonia syndrome after bone marrow transplantation. Am Rev Respir Dis 1993;147:1601-1606.
30. Yanik G, Hellerstedt B, Custer J, et al. Etanercept (Enbrel) administration for idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2002;8:395-400.
31. Peters SG, Afessa B. Acute lung injury after hematopoietic stem cell transplantation. Clin Chest Med 2005;26:561-569, vi.
32. Heggen J, West C, Olson E, et al. Diffuse alveolar hemorrhage in pediatric hematopoietic cell transplant patients. Pediatrics 2002;109:965-971.
33. Ben Abraham R, Paret G, Cohen R, et al. Diffuse alveolar hemorrhage following allogeneic bone marrow transplantation in children. Chest 2003;124:660-664.
34. Afessa B, Tefferi A, Litzow MR, et al. Diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients. Am J Respir Crit Care Med 2002;166:641-645.
35. Haselton DJ, Klekamp JG, Christman BW, et al. Use of high-dose corticosteroids and high-frequency oscillatory ventilation for treatment of a child with diffuse alveolar hemorrhage after bone marrow transplantation: Case report and review of the literature. Crit Care Med 2000;28:245-248.
36. Bojko T, Notterman DA, Greenwald BM, et al. Acute hypoxemic respiratory failure in children following bone marrow transplantation: An outcome and pathologic study. Crit Care Med 1995;23:755-759.
37. Hicks K, Peng D, Gajewski JL. Treatment of diffuse alveolar hemorrhage after allogeneic bone marrow transplant with recombinant factor VIIa. Bone Marrow Transplant 2002;30:975-978.
38. Maiolino A, Biasoli I, Lima J, et al. Engraftment syndrome following autologous hematopoietic stem cell transplantation: Definition of diagnostic criteria. Bone Marrow Transplant 2003;31:393-397.
39. Spitzer TR. Engraftment syndrome following hematopoietic stem cell transplantation. Bone Marrow Transplant 2001;27:893-898.
40. Lee CK, Gingrich RD, Hohl RJ, et al. Engraftment syndrome in autologous bone marrow and peripheral stem cell transplantation. Bone Marrow Transplant 1995;16:175-182.
41. Foncillas MA, Diaz MA, Sevilla J, et al. Engraftment syndrome emerges as the main cause of transplant-related mortality in pediatric patients receiving autologous peripheral blood progenitor cell transplantation. J Pediatr Hematol Oncol 2004;26:492-496.
42. Madero L, Vicent MG, Sevilla J, et al. Engraftment syndrome in children undergoing autologous peripheral blood progenitor cell transplantation. Bone Marrow Transplant 2002;30:355-358.
43. Gonzalez-Vicent M, Marin C, Madero L, et al. Risk score for pediatric intensive care unit admission in children undergoing hematopoietic stem cell transplantation and analysis of predictive factors for survival. J Pediatr Hematol Oncol 2005;27:526-531.
44. Mossad S, Kalaycio M, Sobecks R, et al. Steroids prevent engraftment syndrome after autologous hematopoietic stem cell transplantation without increasing the risk of infection. Bone Marrow Transplant 2005;35:375-381.
45. Wagner T, Dhedin N, Philippe B, et al. Acute eosinophilic pneumonia after allogeneic hematopoietic stem cell transplantation. Ann Hematol 2006;85:202-203.
46. Gross TG, Hoge FJ, Jackson JD, et al. Fatal eosinophilic disease following autologous bone marrow transplantation. Bone Marrow Transplant 1994;14:333-337.
47. Trojan A, Meier R, Licht A, et al. Eosinophilic pneumonia after administration of fludarabine for the treatment of non-Hodgkin's lymphoma. Ann Hematol 2002;81:535-537.
48. Cordonnier C, Fleury-Feith J, Escudier E, et al. Secondary alveolar proteinosis is a reversible cause of respiratory failure in leukemic patients. Am J Respir Crit Care Med 1994;149:788-794.
49. Gulbahce HE, Manivel JC, Jessurun J. Pulmonary cytolytic thrombi: A previously unrecognized complication of bone marrow transplantation. Am J Surg Pathol 2000;24:1147-1152.
50. Woodard JP, Gulbahce E, Shreve M, et al. Pulmonary cytolytic thrombi: A newly recognized complication of stem cell transplantation. Bone Marrow Transplant 2000;25:293-300.
51. Gulbahce HE, Pambuccian SE, Jessurun J, et al. Pulmonary nodular lesions in bone marrow transplant recipients: Impact of histologic diagnosis on patient management and prognosis. Am J Clin Pathol 2004;121:205-210.
52. Morales IJ, Anderson PM, Tazelaar HD, et al. Pulmonary cytolytic thrombi: Unusual complication of hematopoietic stem cell transplantation. J Pediatr Hematol Oncol 2003;25:89-92.
53. Peters A, Manivel JC, Dolan M, et al. Pulmonary cytolytic thrombi after allogeneic hematopoietic cell transplantation: A further histologic description. Biol Blood Marrow Transplant 2005;11:484-485.
54. Uderzo C, Faccini P, Rovelli A, et al. Pulmonary thromboembolism in childhood leukemia: 8-years' experience in a pediatric hematology center. J Clin Oncol 1995;13:2805-2812.
55. Uderzo C, Marraro G, Riva A, et al. Pulmonary thromboembolism in leukaemic children undergoing bone marrow transplantation. Bone Marrow Transplant 1993;11:201-203.
56. Qasim W, Gerritsen B, Veys P. Anticardiolipin antibodies and thromboembolism after BMT. Bone Marrow Transplant 1998;21:845-847.
57. Trobaugh-Lotrario AD, Greffe B, Deterding R, et al. Pulmonary veno-occlusive disease after autologous bone marrow transplant in a child with stage IV neuroblastoma: Case report and literature review. J Pediatr Hematol Oncol 2003;25:405-409.
58. Hackman RC, Madtes DK, Petersen FB, et al. Pulmonary venoocclusive disease following bone marrow transplantation. Transplantation 1989;47:989-992.
59. Troussard X, Bernaudin JF, Cordonnier C, et al. Pulmonary venoocclusive disease after bone marrow transplantation. Thorax 1984;39:956-957.
60. Seguchi M, Hirabayashi N, Fujii Y, et al. Pulmonary hypertension associated with pulmonary occlusive vasculopathy after allogeneic bone marrow transplantation. Transplantation 2000;69:177-179.
61. Kotloff RM, Ahya VN, Crawford SW. Pulmonary complications of solid organ and hematopoietic stem cell transplantation. Am J Respir Crit Care Med 2004;170:22-48.
62. Vaksmann G, Nelken B, Deshildre A, et al. Pulmonary arterial occlusive disease following chemotherapy and bone marrow transplantation for leukaemia. Eur J Pediatr 2002;161:247-249.
63. Limsuwan A, Pakakasama S, Rochanawutanon M, et al. Pulmonary arterial hypertension after childhood cancer therapy and bone marrow transplantation. Cardiology 2006;105:188-194.
64. Shankar S, Choi JK, Dermody TS, et al. Pulmonary hypertension complicating bone marrow transplantation for idiopathic myelofibrosis. J Pediatr Hematol Oncol 2004;26:393-397.
65. Beschorner WE, Saral R, Hutchins GM, et al. Lymphocytic bronchitis associated with graft-versus-host disease in recipients of bone-marrow transplants. N Engl J Med 1978;299:1030-1036.
66. Sevilla J, Gonzalez-Vicent M, Madero L, et al. Early onset of acute immune-mediated lung injury in a child undergoing allogeneic peripheral blood transplantation. Am J Hematol 2002;69:56-58.
67. Atkinson K, Turner J, Biggs JC, et al. An acute pulmonary syndrome possibly representing acute graft-versus-host disease involving the lung interstitium. Bone Marrow Transplant 1991;8:231-234.
68. Yousem SA. The histological spectrum of pulmonary graft-versus-host disease in bone marrow transplant recipients. Hum Pathol 1995;26:668-675.
69. Santo Tomas LH, Loberiza FR, Jr., Klein JP, et al. Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia. Chest 2005;128:153-161.
70. Watkins TR, Chien JW, Crawford SW. Graft versus host-associated pulmonary disease and other idiopathic pulmonary complications after hematopoietic stem cell transplant. Semin Respir Crit Care Med 2005;26:482-489.
71. Dudek AZ, Mahaseth H. Hematopoietic stem cell transplant-related airflow obstruction. Curr Opin Oncol 2006;18:115-119.
72. Dudek AZ, Mahaseth H, DeFor TE, et al. Bronchiolitis obliterans in chronic graft-versus-host disease: Analysis of risk factors and treatment outcomes. Biol Blood Marrow Transplant 2003;9:657-666.
73. Paz HL, Crilley P, Patchefsky A, et al. Bronchiolitis obliterans after autologous bone marrow transplantation. Chest 1992;101:775-778.
74. Kurland G, Michelson P. Bronchiolitis obliterans in children. Pediatr Pulmonol 2005;39:193-208.
75. Boehler A, Chamberlain D, Kesten S, et al. Lymphocytic airway infiltration as a precursor to fibrous obliteration in a rat model of bronchiolitis obliterans. Transplantation 1997;64:311-317.
76. Au WY, Ho JC, Lie AK, et al. Respiratory ciliary function in bone marrow recipients. Bone Marrow Transplant 2001;27:1147-1151.
77. Siegel MJ, Bhalla S, Gutierrez FR, et al. Post-lung transplantation bronchiolitis obliterans syndrome: Usefulness of expiratory thin-section CT for diagnosis. Radiology 2001;220:455-462.
78. Uchiyama H, Uchiyama M, Shishikura A, et al. Bronchiolitis obliterans after bone marrow transplantation: Evaluation with lung scintigraphy. Int J Hematol 1998;68:213-220.
79. Hallstrand TS, Sprenger JD, Agosti JM, et al. Long-term acquisition of allergen-specific IgE and asthma following allogeneic bone marrow transplantation from allergic donors. Blood 2004;104:3086-3090.
80. Rietz H, Plummer AL, Gal AA. Asthma as a consequence of bone marrow transplantation. Chest 2002;122:369-370.
81. Ratjen F, Rjabko O, Kremens B. High-dose corticosteroid therapy for bronchiolitis obliterans after bone marrow transplantation in children. Bone Marrow Transplant 2005;36:135-138.
82. Khalid M, Al Saghir A, Saleemi S, et al. Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation: A preliminary study. Eur Respir J 2005;25:490-493.
83. Fullmer JJ, Fan LL, Dishop MK, et al. Successful treatment of bronchiolitis obliterans in a bone marrow transplant patient with tumor necrosis factor-alpha blockade. Pediatrics 2005;116:767-770.
84. Svendsen UG, Aggestrup S, Heilmann C, et al. Transplantation of a lobe of lung from mother to child following previous transplantation with maternal bone marrow. J Heart Lung Transplant 1999;18:388-390.
85. Heath JA, Kurland G, Spray TL, et al. Lung transplantation after allogeneic marrow transplantation in pediatric patients: The Memorial Sloan-Kettering experience. Transplantation 2001;72:1986-1990.
86. Freudenberger TD, Madtes DK, Curtis JR, et al. Association between acute and chronic graft-versus-host disease and bronchiolitis obliterans organizing pneumonia in recipients of
87. hematopoietic stem cell transplants. Blood 2003;102:3822-3828.
88. Kanda Y, Takahashi T, Imai Y, et al. Bronchiolitis obliterans organizing pneumonia after syngeneic bone marrow transplantation for acute lymphoblastic leukemia. Bone Marrow Transplant 1997;19:1251-1253.
89. Mathew P, Bozeman P, Krance RA, et al. Bronchiolitis obliterans organizing pneumonia (BOOP) in children after allogeneic bone marrow transplantation. Bone Marrow Transplant 1994;13:221-223.
90. Battistini E, Dini G, Savioli C, et al. Bronchiolitis obliterans organizing pneumonia in three children with acute leukaemias treated with cytosine arabinoside and anthracyclines. Eur Respir J 1997;10:1187-1190.
91. Ishii T, Manabe A, Ebihara Y, et al. Improvement in bronchiolitis obliterans organizing pneumonia in a child after allogeneic bone marrow transplantation by a combination of oral prednisolone and low dose erythromycin. Bone Marrow Transplant 2000;26:907-910.
92. Kleinau I, Perez-Canto A, Schmid HJ, et al. Bronchiolitis obliterans organizing pneumonia and chronic graft-versus-host disease in a child after allogeneic bone marrow transplantation. Bone Marrow Transplant 1997;19:841-844.
93. Palmas A, Tefferi A, Myers JL, et al. Late-onset noninfectious pulmonary complications after allogeneic bone marrow transplantation. Br J Haematol 1998;100:680-687.
94. Carpenter PA, Sanders JE. Late effects after hemopoetic cell transplantation. In: Mehta P, editor. Pediatric stem cell transplantation. Sudbury, MA: Jones and Bartlett Publishers; 2004. p 413-455.
95. Wolfe J, Grier HE, Klar N, et al. Symptoms and suffering at the end of life in children with cancer. N Engl J Med 2000;342:326-333.
96. Serota FT, August CS, Koch PA, et al. Pulmonary function in patients undergoing bone marrow transplantation. Med Pediatr Oncol 1984;12:137-143.
97. Uderzo C, Rovelli A, Meloni G, et al. Evaluation of late side-effects after bone marrow transplantation in children with leukemia. Bone Marrow Transplant 1991;8(Suppl 1):44-46.
98. Kaplan EB, Wodell RA, Wilmott RW, et al. Chronic graft-versus-host disease and pulmonary function. Pediatr Pulmonol 1992;14:141-148.
99. Kaplan EB, Wodell RA, Wilmott RW, et al. Late effects of bone marrow transplantation on pulmonary function in children. Bone Marrow Transplant 1994;14:613-621.
100. Schultz KR, Green GJ, Wensley D, et al. Obstructive lung disease in children after allogeneic bone marrow transplantation. Blood 1994;84:3212-3220.
101. Quigley PM, Yeager AM, Loughlin GM. The effects of bone marrow transplantation on pulmonary function in children. Pediatr Pulmonol 1994;18:361-367.
102. Arvidson J, Bratteby LE, Carlson K, et al. Pulmonary function after autologous bone marrow transplantation in children. Bone Marrow Transplant 1994;14:117-123.
103. Rovelli A, Pezzini C, Silvestri D, et al. Cardiac and respiratory function after bone marrow transplantation in children with leukaemia. Bone Marrow Transplant 1995;16:571-576.
104. Nenadov Beck M, Meresse V, Hartmann O, et al. Long-term pulmonary sequelae after autologous bone marrow transplantation in children without total body irradiation. Bone Marrow Transplant 1995;16:771-775.
105. Nysom K, Holm K, Hesse B, et al. Lung function after allogeneic bone marrow transplantation for leukaemia or lymphoma. Arch Dis Child 1996;74:432-436.
106. Fanfulla F, Locatelli F, Zoia MC, et al. Pulmonary complications and respiratory function changes after bone marrow transplantation in children. Eur Respir J 1997;10:2301-2306.
107. Neve V, Foot AB, Michon J, et al. Longitudinal clinical and functional pulmonary follow-up after megatherapy, fractionated total body irradiation, and autologous bone marrow transplantation for metastatic neuroblastoma. Med Pediatr Oncol 1999;32:170-176.
108. Cerveri I, Zoia MC, Fulgoni P, et al. Late pulmonary sequelae after childhood bone marrow transplantation. Thorax 1999;54:131-135.
109. Leneveu H, Bremont F, Rubie H, et al. Respiratory function in children undergoing bone marrow transplantation. Pediatr Pulmonol 1999;28:31-38.
110. Fulgoni P, Zoia MC, Corsico A, et al. Lung function in survivors of childhood acute lymphoblastic leukemia. Chest 1999;116:1163-1167.
111. Cerveri I, Fulgoni P, Giorgiani G, et al. Lung function abnormalities after bone marrow transplantation in children: Has the trend recently changed? Chest 2001;120:1900-1906.
112. Bruno B, Souillet G, Bertrand Y, et al. Effects of allogeneic bone marrow transplantation on pulmonary function in 80 children in a single paediatric centre. Bone Marrow Transplant 2004;34:143-147.
113. Frisk P, Arvidson J, Bratteby LE, et al. Pulmonary function after autologous bone marrow transplantation in children: A long-term prospective study. Bone Marrow Transplant 2004;33:645-650.
114. Hoffmeister PA, Madtes DK, Storer BE, et al. Pulmonary function in long-term survivors of pediatric hematopoietic cell transplantation. Pediatr Blood Cancer 2006;47:594-606.